Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 0 · FY2024 0
Real-estate / development arm associated with the MedLog Georgia pharma-logistics group.
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|
| 3,175 | 1,108 | 1,338 | 4,099 | 4,165 | 3,985 | +4.6% | |
| 9,774 | 10,499 | 14,835 | 20,078 | 22,979 | 28,178 | +23.6% | |
| TOTAL ASSETS | 12,949 | 11,607 | 16,173 | 24,177 | 27,144 | 32,163 | +20.0% |
| 10,065 | 3,089 | 836 | 4,163 | 3,436 | 7,262 | -6.3% | |
| Total Non-Current Liabilities | 0 | 376 | 0 | 3,928 | 4,444 | 6,629 | +105.0% |
| TOTAL LIABILITIES | 10,065 | 3,465 | 836 | 8,091 | 7,880 | 13,891 | +6.7% |
| 2,884 | 8,142 | 15,337 | 16,086 | 19,264 | 18,272 | +44.7% | |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | |||||||
| Total Debt | 0 | 654 | 618 | 4,826 | 7,349 | 11,028 | +102.6% |
| Cash & Equivalents | 2,946 | 337 | 612 | 2,949 | 2,091 | 216 | -40.7% |
| Net Debt | 2,946 | 318 | 6 | 1,877 | 5,258 | 10,812 | nmf |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →